Pacific Biosciences of California, Inc. (PACB)
1.28
-0.07
(-5.19%)
USD |
NASDAQ |
Aug 24, 16:00
1.32
+0.04
(+3.12%)
After-Hours: 05:14
Pacific Biosciences of California Debt to Equity Ratio : -21.26 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.26 |
| March 31, 2026 | 297.29 |
| December 31, 2025 | 131.32 |
| September 30, 2025 | 19.40 |
| June 30, 2025 | 11.37 |
| March 31, 2025 | 7.629 |
| December 31, 2024 | 1.332 |
| September 30, 2024 | 2.032 |
| June 30, 2024 | 1.877 |
| March 31, 2024 | 1.435 |
| December 31, 2023 | 1.332 |
| September 30, 2023 | 1.225 |
| June 30, 2023 | 1.460 |
| March 31, 2023 | 1.365 |
| December 31, 2022 | 1.686 |
| September 30, 2022 | 1.513 |
| June 30, 2022 | 1.394 |
| March 31, 2022 | 1.296 |
| December 31, 2021 | 1.211 |
| September 30, 2021 | 1.133 |
| June 30, 2021 | 3.624 |
| March 31, 2021 | 3.338 |
| December 31, 2020 | 0.1252 |
| September 30, 2020 | 0.3321 |
| June 30, 2020 | 1.062 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7428 |
| December 31, 2019 | 1.123 |
| September 30, 2019 | 1.22 |
| June 30, 2019 | 0.8288 |
| March 31, 2019 | 0.6676 |
| December 31, 2018 | 0.1285 |
| September 30, 2018 | 0.1091 |
| June 30, 2018 | 0.1652 |
| March 31, 2018 | 0.135 |
| December 31, 2017 | 0.1584 |
| September 30, 2017 | 0.1335 |
| June 30, 2017 | 0.1131 |
| March 31, 2017 | 0.2404 |
| December 31, 2016 | 0.1944 |
| September 30, 2016 | 0.1623 |
| June 30, 2016 | 0.1458 |
| March 31, 2016 | 0.1776 |
| December 31, 2015 | 0.2114 |
| September 30, 2015 | 0.3803 |
| June 30, 2015 | 0.4571 |
| March 31, 2015 | 0.3756 |
| December 31, 2014 | 0.257 |
| September 30, 2014 | 0.2755 |
| June 30, 2014 | 0.2442 |
| March 31, 2014 | 0.213 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Illumina, Inc. | 0.8904 |
| Agilent Technologies, Inc. | 0.4711 |
| Bio-Rad Laboratories, Inc. | 0.191 |
| Danaher Corp. | 0.5298 |
| Thermo Fisher Scientific, Inc. | 0.8077 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 751.85M |
| Total Liabilities (Quarterly) | 785.06M |
| Shareholders Equity (Quarterly) | -33.21M |
| Current Ratio | 4.922 |
| Net Debt Paydown Yield | -0.27% |